Mutation Screening and Association Study of the Folylpolyglutamate Synthetase (FPGS) Gene with Susceptibility to Childhood Acute Lymphoblastic Leukemia

  • Piwkham, Duangjai (Department of Pathology, Faculty of Medicine Ramathibodi Hospital, Mahidol University) ;
  • Siriboonpiputtana, Teerapong (Department of Pathology, Faculty of Medicine Ramathibodi Hospital, Mahidol University) ;
  • Beuten, Joke (Department of Pediatrics, University of Texas Health Science Center at San Antonio) ;
  • Pakakasama, Samart (Department of Pediatrics, Faculty of Medicine Ramathibodi Hospital, Mahidol University) ;
  • Gelfond, Jonathan AL (Epidemiology and Biostatistics, University of Texas Health Science Center at San Antonio) ;
  • Paisooksantivatana, Karan (Department of Pathology, Faculty of Medicine Ramathibodi Hospital, Mahidol University) ;
  • Tomlinson, Gail E (Department of Pediatrics, University of Texas Health Science Center at San Antonio) ;
  • Rerkamnuaychoke, Budsaba (Department of Pathology, Faculty of Medicine Ramathibodi Hospital, Mahidol University)
  • Published : 2015.06.26


Background: Folylpolyglutamate synthetase (FPGS), an important enzyme in the folate metabolic pathway, plays a central role in intracellular accumulation of folate and antifolate in several mammalian cell types. Loss of FPGS activity results in decreased cellular levels of antifolates and consequently to polyglutamatable antifolates in acute lymphoblastic leukemia (ALL). Materials and Methods: During May 1997 and December 2003, 134 children diagnosed with ALL were recruited from one hospital in Thailand. We performed a mutation analysis in the coding regions of the FPGS gene and the association between single nucleotide polymorphisms (SNPs) within FPGS in a case-control sample of childhood ALL patients. Mutation screening was conducted by polymerase chain reaction-single strand conformation polymorphism (PCR-SSCP) and subsequently with direct sequencing (n=72). Association analysis between common FPGS variants and ALL risk was done in 98 childhood ALL cases and 95 healthy volunteers recruited as controls. Results: Seven SNPs in the FPGS coding region were identified by mutation analysis, 3 of which (IVS13+55C>T, g.1297T>G, and g.1508C>T) were recognized as novel SNPs. Association analysis revealed 3 of 6 SNPs to confer significant increase in ALL risk these being rs7039798 (p=0.014, OR=2.14), rs1544105 (p=0.010, OR= 2.24), and rs10106 (p=0.026, OR=1.99). Conclusions: These findings suggested that common genetic polymorphisms in the FPGS coding region including rs7039789, rs1544105, and rs10106 are significantly associated with increased ALL risk in Thai children.


Folylpolyglutamate synthetase;acute lymphoblastic leukemia;single nucleotide polymorphism


Supported by : Thailand Research Fund (TRF), Texas Higher Education Coordinating Board


  1. Barredo J, Moran RG (1992). Determinants of antifolate cytotoxicity: folylpolyglutamate synthetase activity during cellular proliferation and development. Mol Pharmacol, 42, 687-94.
  2. Barrett JC, Fry B, Maller J, et al (2005) Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics, 21, 263-5.
  3. Bastos E, Cravador A, Azevedo J, et al (2001). Single strand conformation polymorphism (SSCP) detection in six genes in Portuguese indigenous sheep breed "Churra da Terra Quente". Biotechnol Agron Soc Environ, 5, 7-15.
  4. Buffler PA, Kwan ML, Reynolds P, et al (2005). Environmental and genetic risk factors for childhood leukemia: appraising the evidence. Cancer Invest, 23, 60-75.
  5. Chen L, Qi H, Korenberg J, et al (1996). Purification and properties of human cytosolic folylpoly-gamma-glutamate synthetase and organization, localization, and differential splicing of its gene. J Biol Chem, 271, 13077-87.
  6. Daga A, Tighe JE and Calabi F (1992). Leukaemia/Drosophila homology. Nature, 356, 484.
  7. de Beaumais TA and Jacqz-Aigrain E (2012). Intracellular disposition of methotrexate in acute lymphoblastic leukemia in children. Curr Drug Metab, 13, 822-34.
  8. de Jonge R, Tissing WJ, Hooijberg JH, et al (2009). Polymorphisms in folate-related genes and risk of pediatric acute lymphoblastic leukemia. Blood, 5, 2284-9.
  9. Duthie SJ (1999). Folic acid deficiency and cancer: mechanisms of DNA instability. Br Med Bull, 55, 578-52.
  10. Duthie SJ, Narayanan S, Sharp L, et al (2004). Folate, DNA stability and colo-rectal neoplasia. Proc Nutr Soc, 63, 571-8.
  11. Emerenciano M, Koifman S and Pombo-de-Oliveira MS (2007). Acute leukemia in early childhood. Braz J Med Biol Res, 40, 749-60.
  12. Gomez-Gomez Y, Organista-Nava J, Rangel-Rodriguez CA, et al (2014). Effect of folylpolyglutamate synthase A22G polymorphism on the risk and survival of patients with acute lymphoblastic leukemia. Oncol Lett, 8, 731-5.
  13. Huang L, Deng D, Peng Z, et al (2015). Polymorphisms in the methylenetetrahydrofolate reductase gene (MTHFR) are associated with susceptibility to adult myeloid leukemia in a Chinese population. Cancer Epidemiol,
  14. Inaba H, Greaves M and Mullighan CG (2013). Acute lymphoblastic leukaemia. Lancet, 1, 1943-55.
  15. Jiang Y, Hou J, Zhang Q, et al (2013). The MTHFR C677T polymorphism and risk of acute lymphoblastic leukemia: an updated meta-analysis based on 37 case-control studies. Asian Pac J Cancer Prev, 14, 6357-62.
  16. Karathanasis NV, Choumerianou DM and Kalmanti M (2009). Gene polymorphisms in childhood ALL. Pediatr Blood Cancer, 52, 318-23.
  17. Koppen IJ, Hermans FJ and Kaspers GJ (2010). Folate related gene polymorphisms and susceptibility to develop childhood acute lymphoblastic leukaemia. Br J Haematol, 148, 3-14.
  18. Kreile M, Rots D, Piekuse L, et al (2014). Lack of Association between Polymorphisms in Genes MTHFR and MDR1 with risk of childhood acute lymphoblastic Leukemia. Asian Pac J Cancer Prev, 15, 9707-11.
  19. Li X, Liao Q, Zhang S, et al (2014). Association of methylenetetrahytrofolate reductase (MTHFR) C677T and A1298C polymorphisms with the susceptibility of childhood acute lymphoblastic leukemia (ALL) in Chinese population. Eur J Med Res, 19, 5.
  20. Liani E, Rothem L, Bunni MA, et al (2003). Loss of folylpoly-gamma-glutamate synthetase activity is a dominant mechanism of resistance to polyglutamylation-dependent novel antifolates in multiple human leukemia sublines. Int J Cancer, 20, 587-99.
  21. Liu SG, Gao C, Zhang RD, et al (2013). FPGS rs1544105 polymorphism is associated with treatment outcome in pediatric B-cell precursor acute lymphoblastic leukemia. Cancer Cell Int, 13, 107.
  22. Mlodzik M and Gehring WJ (1987). Expression of the caudal gene in the germ line of Drosophila: formation of an RNA and protein gradient during early embryogenesis. Cell, 48, 465-78.
  23. Moran RG and Colman PD (1984). Measurement of folylpolyglutamate synthetase in mammalian tissues. Anal Biochem, 140, 326-42.
  24. Panetta JC, Sparreboom A, Pui CH, et al (2010). Modeling mechanisms of in vivo variability in methotrexate accumulation and folate pathway inhibition in acute lymphoblastic leukemia cells. PLoS Comput Biol, 2, 1001019.
  25. Raz S, Stark M and Assaraf YG (2014). Binding of a Smad4/Ets-1 complex to a novel intragenic regulatory element in exon12 of FPGS underlies decreased gene expression and antifolate resistance in leukemia. Oncotarget, 5, 9183-98.
  26. Skibola CF, Smith MT and Hubbard A, et al (2002). Polymorphisms in the thymidylate synthase and serine hydroxymethyltransferase genes and risk of adult acute lymphocytic leukemia. Blood, 99, 3786-91.
  27. Stark M, Wichman C, Avivi I, et al (2009). Aberrant splicing of folylpolyglutamate synthetase as a novel mechanism of antifolate resistance in leukemia. Blood, 113, 4362-9.
  28. Taylor SM, Freemantle SJ and Moran RG (1995). Structural organization of the human folypoly-gamma-glutamate synthetase gene: evidence for a single genomic locus. Cancer Res, 55, 6030-4.
  29. Thirumaran RK, Gast A, Flohr T, et al (2005). MTHFR genetic polymorphisms and susceptibility to childhood acute lymphoblastic leukemia. Blood, 1, 2590-1.
  30. Wagner C (2001). Biochemical role of folate in cellular metabolism. Clin Res Regul Aff, 18, 161-80.
  31. Yang W, Trevino LR, Yang JJ, et al (2010). ARID5B SNP rs10821936 is associated with risk of childhood acute lymphoblastic leukemia in blacks and contributes to racial differences in leukemia incidence. Leukemia, 24, 894-6.
  32. Yang L, Liu L, Wang J, et al (2011). Polymorphisms in folate-related genes: impact on risk of adult acute lymphoblastic leukemia rather than pediatric in Han Chinese. Leuk Lymphoma, 52, 1770-6.

Cited by

  1. Effect of Antioxidants and Apoptosis Inhibitors on Cryopreservation of Murine Germ Cells Enriched for Spermatogonial Stem Cells vol.11, pp.8, 2016,
  2. Multiplex RT-PCR Assay for Detection of Common Fusion Transcripts in Acute Lymphoblastic Leukemia and Chronic Myeloid Leukemia Cases vol.17, pp.2, 2016,
  3. Mutation of the nm23-H1 gene has a non-dominant role in colorectal adenocarcinoma vol.5, pp.1, 2016,